We are monitoring the impact of COVID-19 & Recession alarm on Taiwan OTC Drugs Market Get in touch with us for detailed analysis Know More
Share on

Taiwan OTC Drugs Market Research Report - By Formulation Type, Product Type, Distribution - Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 745
Pages: 135

The size of Taiwan Over the Counter (OTC) Drugs Market was worth USD 1.90 billion in 2022 and estimated to reach USD 2.53 billion by the end of 2027 with a growing potential of 5.82%. Taiwan Over the Counter Drugs market accounts for 3.5% of the total Asia-Pacific OTC drugs market

Over the counter, the term mentions pharmaceuticals, which are bought across the counter without any need for a physician's prescription. OTC drugs are used to treat and prevent minor disorders. As a growing aging population, there is an increasing push to be able to license OTC medicines for the use of treatment of chronic conditions. The aging population (>65) accounts for 11.4% of the total population in Taiwan.

The government has reduced tax for the pharmaceutical industry to encourage many foreign multinational companies to invest in Taiwan. The government has recently made 13 prescription drugs available over the counter, making the purchase of the drugs more convenient. However, the government has also cut the price of drugs funded under national health programs.

Lower costs than prescription drugs drive the Taiwan OTC pharmaceutical market, growing preference for using OTC drugs for minor ailments, increased health care expenditure, Government policies like healthcare infrastructure and insurance system. Cost sensitivity of production is the major factor inhibiting the growth of the market.

This research report is segmented & sub-segmented the Taiwan OTC Drugs Market into the following categories:

  • By Formulation Type                              
    • Tablets      
    • Liquids      
    • Ointments               
    • Sprays       
  • By Product Type                       
    • Cough, Cold, and Flu Drugs
    • Analgesics
    • Dermatologicals    
    • Gastrointestinal Drugs
    • Antiseptics              
    • Anti-Allergy Drugs
    • Smoking Cessation Aids     
    • Ophthalmic Drugs
    • Vitamins and Minerals       
    • Sleep Aids             
    • Weight Loss/Diet Products            
    • Others (Ear Drops & Diuretics)     
  • By Distribution Channel                         
    • Pharmacies/Drugstores     
    • Supermarkets/Hypermarkets         
    • Convenience stores            
    • Others (Online Drugstores)

Prominent companies leading Taiwan Over the Counter Drugs market are Eu Yan Sang International Ltd, Bayer AG, Johnson & Johnson, GlaxoSmithKline plc, Merck Pte Ltd, Sunward Pharmaceutical Pte Ltd, Beacons Pharmaceuticals (Pte) Ltd.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Formulation Type                              

                                5.1.1 Tablets      

                                5.1.2 Liquids      

                                5.1.3 Ointments               

                                5.1.4 Sprays       

                5.2 By Product Type                       

                                5.2.1 Cough, Cold and Flu Drugs

                                5.2.2 Analgesics

                                5.2.3 Dermatologicals    

                                5.2.4 Gastrointestinal Drugs

                                5.2.5 Antiseptics              

                                5.2.6 Anti-Allergy Drugs

                                5.2.7 Smoking Cessation Aids     

                                5.2.8 Ophthalmic Drugs

                                5.2.9 Vitamins and Minerals       

                                5.2.10 Sleep Aids             

                                5.2.11 Weight Loss/Diet Products            

                                5.2.12 Others (Ear Drops & Diuretics)     

                5.3 By Distribution Channel                         

                                5.3.1 Pharmacies/Drugstores     

                                5.3.2 Supermarkets/Hypermarkets         

                                5.3.3 Convenience stores            

                                5.3.4 Others (Online Drugstores)             

6. Strategic Analysis                                       

                6.1 PESTLE analysis                         

                                6.1.1 Political     

                                6.1.2 Economic 

                                6.1.3 Social         

                                6.1.4 Technological         

                                6.1.5 Legal          

                                6.1.6 Environmental       

                6.2 Porter’s Five analysis                              

                                6.2.1 Bargaining Power of Suppliers        

                                6.2.2 Bargaining Power of Consumers    

                                6.2.3 Threat of New Entrants     

                                6.2.4 Threat of Substitute Products and Services              

                                6.2.5 Competitive Rivalry within the Industry     

7. Market Leaders' Analysis                                        

                7.1 Johnson & Johnson                 

                                7.1.1 Overview 

                                7.1.2 Product Analysis   

                                7.1.3 Strategic Evaluation and Operations            

                                7.1.4 Financial analysis  

                                7.1.5 Legal issues             

                                7.1.6 Recent Developments       

                                7.1.7 SWOT analysis       

                                7.1.8 Analyst View          

                7.2 Sinphar pharmaceutical co ltd                             

                7.3 China Chemical & Pharmaceutical Co., Ltd                     

                7.4 GlaxoSmithKline Plc                                

                7.5 Daiichi Sankyo Co,. Ltd                           

                7.6 Bayer Health care                    

                7.7 Merck Ltd                    

                7.8 Novartis                       

8. Competitive Landscape                                           

                8.1 Market share analysis                            

                8.2 Merger and Acquisition Analysis                       

                8.3 Agreements, collaborations and Joint Ventures                         

                8.4 New Product Launches                         

9. Expert Opinions                                          

                9.1 Market Outlook                        

                9.2 Investment Opportunities                   

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

Taiwan Over the Counter Drugs market

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

1950


pdf excel
$

2250


pdf excel powerbi
$

3200


excel
$

1200

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1950

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample